Balchem Corporation (NASDAQ:BCPC) Getting Somewhat Favorable Media Coverage, Analysis Shows

Bruno Cirelli
Agosto 9, 2017

Salem Investment Counselors Inc sold 5,700 shares as Balchem Corp (BCPC)'s stock declined 5.76%. The latest reports which are outstanding on Monday 7th of August state 0 analysts have a rating of "strong buy", 1 analysts "buy", 1 analysts "neutral", 0 analysts "sell" and 1 analysts "strong sell". Hancock Hldgs Communications invested 0.04% in Balchem Corporation (NASDAQ:BCPC). Municipal Employees Retirement System of MI raised its position in Balchem Corporation by 4.0% in the second quarter. Cardinal Capital Management boosted its stake in shares of Balchem Corporation by 12.9% in the second quarter.

The company is trading up by 1.25 percent from yesterday's close. Daruma Cap Management Limited Co stated it has 0.14% of its portfolio in Balchem Corporation (NASDAQ:BCPC). MA raised its position in Balchem Corporation by 9.6% in the second quarter. Following the completion of the sale, the director now owns 25,739 shares in the company, valued at approximately $2,087,175.51. Great West Life Assurance Co.

Shares of Balchem Corporation (NASDAQ BCPC) opened at 78.00 on Friday. The company has a market cap of $2.39 billion, a PE ratio of 40.33 and a beta of 1.10. The firm has a 50-day moving average of $78.45 and a 200 day moving average of $81.18. Balchem Corporation has a one year low of $62.92 and a one year high of $89.50.

Balchem Corporation (NASDAQ:BCPC) last issued its earnings results on Friday, August 4th. The basic materials company reported $0.64 earnings per share for the quarter, beating the consensus estimate of $0.63 by $0.01. Balchem Corporation had a net margin of 10.99% and a return on equity of 14.99%.

The chemical company posted revenue of $147.1 million in the period. Next quarter's EPS is expected be $0.65 with next year's EPS projected to be $2.80.

COPYRIGHT VIOLATION NOTICE: This news story was published by Transcript Daily and is the property of of Transcript Daily. The legal version of this article can be viewed at

Separately, BidaskClub lowered Balchem Corporation from a "hold" rating to a "sell" rating in a report on Wednesday, June 21st.

In other news, Director Edward Mcmillan sold 2,557 shares of the stock in a transaction that occurred on Thursday, June 15th. The shares were sold at an average price of $81.09, for a total value of $207,347.13. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Balchem Corporation, launched on January 30, 1967, is involved in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization and industrial markets. The Firm operates in four divisions: Human Nutrition & Health, Animal Nutrition & Health, Specialty Products and Industrial Products.

Altre relazioni OverNewsmagazine

Discuti questo articolo